A possible explanation is that tissue expression of ACE2 may play a key role in the progression of COVID-19 patients with obesity, since obese individuals have increased AT mass that leads to an elevated number of ACE2-expressing cells and therefore an increased risk of SARS-CoV-2 infection (126, 127). Here, ACE2 is linked to COVID-19.